# Study of Oglemilast for the Treatment of Asthma

> **NCT00322686** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 6 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Oglemilast
- **DRUG:** Placebo then Oglemilast

## Key facts

- **NCT ID:** NCT00322686
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322686, "Study of Oglemilast for the Treatment of Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00322686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*